FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367549649> ?p ?o ?g. }

• W4367549649 endingPage "525" @default.
• W4367549649 startingPage "515" @default.
• W4367549649 abstract "Anthracyclines can cause cancer therapy-related cardiac dysfunction (CTRCD). We aimed to assess whether statins prevent decline in left ventricular ejection fraction (LVEF) in anthracycline-treated patients at increased risk for CTRCD.In this multicenter double-blinded, placebo-controlled trial, patients with cancer at increased risk of anthracycline-related CTRCD (per ASCO guidelines) were randomly assigned to atorvastatin 40 mg or placebo once-daily. Cardiovascular magnetic resonance (CMR) imaging was performed before and within 4 weeks after anthracyclines. Blood biomarkers were measured at every cycle. The primary outcome was post-anthracycline LVEF, adjusted for baseline. CTRCD was defined as a fall in LVEF by >10% to <53%. Secondary endpoints included left ventricular (LV) volumes, CTRCD, CMR tissue characterization, high sensitivity troponin I (hsTnI), and B-type natriuretic peptide (BNP).We randomized 112 patients (56.9 ± 13.6 years, 87 female, and 73 with breast cancer): 54 to atorvastatin and 58 to placebo. Post-anthracycline CMR was performed 22 (13-27) days from last anthracycline dose. Post-anthracycline LVEF did not differ between the atorvastatin and placebo groups (57.3 ± 5.8% and 55.9 ± 7.4%, respectively) when adjusted for baseline LVEF (P = 0.34). There were no significant between-group differences in post-anthracycline LV end-diastolic (P = 0.20) or end-systolic volume (P = 0.12), CMR myocardial edema and/or fibrosis (P = 0.06-0.47), or peak hsTnI (P ≥ 0.99) and BNP (P = 0.23). CTRCD incidence was similar (4% versus 4%, P ≥ 0.99). There was no difference in adverse events.In patients at increased risk of CTRCD, primary prevention with atorvastatin during anthracycline therapy did not ameliorate early LVEF decline, LV remodeling, CTRCD, change in serum cardiac biomarkers, or CMR myocardial tissue changes.NCT03186404." @default.
• W4367549649 created "2023-05-01" @default.
• W4367549649 creator A5001022043 @default.
• W4367549649 creator A5004093435 @default.
• W4367549649 creator A5009052415 @default.
• W4367549649 creator A5014836666 @default.
• W4367549649 creator A5022801937 @default.
• W4367549649 creator A5026467222 @default.
• W4367549649 creator A5027291703 @default.
• W4367549649 creator A5028042700 @default.
• W4367549649 creator A5038824361 @default.
• W4367549649 creator A5042204708 @default.
• W4367549649 creator A5042779003 @default.
• W4367549649 creator A5048364915 @default.
• W4367549649 creator A5054639337 @default.
• W4367549649 creator A5060475589 @default.
• W4367549649 creator A5061728903 @default.
• W4367549649 creator A5074267679 @default.
• W4367549649 creator A5074500372 @default.
• W4367549649 creator A5079554811 @default.
• W4367549649 creator A5084955100 @default.
• W4367549649 creator A5085305707 @default.
• W4367549649 creator A5089443762 @default.
• W4367549649 date "2023-04-29" @default.
• W4367549649 modified "2023-10-01" @default.
• W4367549649 title "Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines" @default.
• W4367549649 cites W181903954 @default.
• W4367549649 cites W2013429872 @default.
• W4367549649 cites W2121050972 @default.
• W4367549649 cites W2143967622 @default.
• W4367549649 cites W2147646179 @default.
• W4367549649 cites W2164111588 @default.
• W4367549649 cites W2343510745 @default.
• W4367549649 cites W2560560709 @default.
• W4367549649 cites W2577541469 @default.
• W4367549649 cites W2803622815 @default.
• W4367549649 cites W2908389530 @default.
• W4367549649 cites W2912775094 @default.
• W4367549649 cites W2976106895 @default.
• W4367549649 cites W2976359791 @default.
• W4367549649 cites W2994960976 @default.
• W4367549649 cites W3001617274 @default.
• W4367549649 cites W3008757291 @default.
• W4367549649 cites W3092865540 @default.
• W4367549649 cites W3101140789 @default.
• W4367549649 cites W3118418206 @default.
• W4367549649 cites W3135821700 @default.
• W4367549649 cites W4291238068 @default.
• W4367549649 cites W4293068501 @default.
• W4367549649 cites W4293217929 @default.
• W4367549649 cites W4309336665 @default.
• W4367549649 doi "https://doi.org/10.1093/ehjcvp/pvad031" @default.
• W4367549649 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37120736" @default.
• W4367549649 hasPublicationYear "2023" @default.
• W4367549649 type Work @default.
• W4367549649 citedByCount "4" @default.
• W4367549649 countsByYear W43675496492023 @default.
• W4367549649 crossrefType "journal-article" @default.
• W4367549649 hasAuthorship W4367549649A5001022043 @default.
• W4367549649 hasAuthorship W4367549649A5004093435 @default.
• W4367549649 hasAuthorship W4367549649A5009052415 @default.
• W4367549649 hasAuthorship W4367549649A5014836666 @default.
• W4367549649 hasAuthorship W4367549649A5022801937 @default.
• W4367549649 hasAuthorship W4367549649A5026467222 @default.
• W4367549649 hasAuthorship W4367549649A5027291703 @default.
• W4367549649 hasAuthorship W4367549649A5028042700 @default.
• W4367549649 hasAuthorship W4367549649A5038824361 @default.
• W4367549649 hasAuthorship W4367549649A5042204708 @default.
• W4367549649 hasAuthorship W4367549649A5042779003 @default.
• W4367549649 hasAuthorship W4367549649A5048364915 @default.
• W4367549649 hasAuthorship W4367549649A5054639337 @default.
• W4367549649 hasAuthorship W4367549649A5060475589 @default.
• W4367549649 hasAuthorship W4367549649A5061728903 @default.
• W4367549649 hasAuthorship W4367549649A5074267679 @default.
• W4367549649 hasAuthorship W4367549649A5074500372 @default.
• W4367549649 hasAuthorship W4367549649A5079554811 @default.
• W4367549649 hasAuthorship W4367549649A5084955100 @default.
• W4367549649 hasAuthorship W4367549649A5085305707 @default.
• W4367549649 hasAuthorship W4367549649A5089443762 @default.
• W4367549649 hasConcept C121608353 @default.
• W4367549649 hasConcept C126322002 @default.
• W4367549649 hasConcept C142724271 @default.
• W4367549649 hasConcept C164705383 @default.
• W4367549649 hasConcept C204787440 @default.
• W4367549649 hasConcept C27081682 @default.
• W4367549649 hasConcept C2776694085 @default.
• W4367549649 hasConcept C2776802502 @default.
• W4367549649 hasConcept C2776839432 @default.
• W4367549649 hasConcept C2777482532 @default.
• W4367549649 hasConcept C2778198053 @default.
• W4367549649 hasConcept C2778233292 @default.
• W4367549649 hasConcept C530470458 @default.
• W4367549649 hasConcept C71924100 @default.
• W4367549649 hasConcept C78085059 @default.
• W4367549649 hasConceptScore W4367549649C121608353 @default.
• W4367549649 hasConceptScore W4367549649C126322002 @default.
• W4367549649 hasConceptScore W4367549649C142724271 @default.
• W4367549649 hasConceptScore W4367549649C164705383 @default.

• next